XBiotech Inc (XBIT) Stock Price

XBITStock

$2.30−27.81%52W

Market Cap$70.12M

P/E—

PEG Ratio—

Div yield—

Beta0.80

XBIT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-15.40%

Price vs S&P 500 (4W)-1.29%

VGM Score39.56

Book Value / Share (Quarterly)$4.43

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.39

Price vs S&P 500 (YTD)-15.31%

Gross Margin (TTM)83.79%

Net Profit Margin (TTM)-820.45%

EPS (TTM)$-1.32

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-1.32

EPS (Annual)$-1.30

ROI (Annual)-20.26%

Gross Margin (Annual)83.79%

Cash / Share (Quarterly)$3.79

ROA (Last FY)-19.59%

EBITD / Share (TTM)$-1.54

ROE (5Y Avg)-11.20%

Operating Margin (TTM)-860.10%

Cash Flow / Share (Annual)$-1.32

P/B Ratio0.56x

P/B Ratio (Quarterly)0.53x

Net Income / Employee (Annual)$-458,800

EV / Revenue (TTM)-10.09x

Net Interest Coverage (TTM)-105.08x

ROA (TTM)-25.06%

EV / EBITDA (TTM)-0.06x

EPS Incl Extra (Annual)$-1.30

Current Ratio (Annual)16.01x

Quick Ratio (Quarterly)38.60x

3-Month Avg Trading Volume0.03M

52-Week Price Return-27.81%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)18.70x

Asset Turnover (Annual)0.02x

52-Week High$3.61

EPS Excl Extra (Annual)$-1.30

CapEx CAGR (5Y)-40.04%

26-Week Price Return-4.15%

Quick Ratio (Annual)15.88x

13-Week Price Return-6.85%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)39.03x

Enterprise Value$-40.46M

Asset Turnover (TTM)0.02x

Book Value / Share Growth (5Y)-17.30%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-837.66%

Cash / Share (Annual)$4.12

3-Month Return Std Dev25.35%

Net Income / Employee (TTM)$-472,500

ROE (Last FY)-21.40%

Net Interest Coverage (Annual)-24.03x

EPS Basic Excl Extra (Annual)$-1.30

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.32

Receivables Turnover (Annual)0.00x

ROI (TTM)-26.10%

P/S Ratio (TTM)18.70x

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-46.12%

Year-to-Date Return-3.35%

5-Day Price Return1.76%

EPS Normalized (Annual)$-1.30

ROA (5Y Avg)-10.66%

Net Profit Margin (Annual)-820.45%

Month-to-Date Return3.59%

EBITD / Share (Annual)$-1.34

Operating Margin (Annual)-860.10%

ROI (5Y Avg)-10.97%

EPS Basic Excl Extra (TTM)$-1.32

P/B Ratio (Annual)0.51x

Pretax Margin (TTM)-837.66%

Book Value / Share (Annual)$4.60

Price vs S&P 500 (13W)-9.65%

Beta0.80x

P/FCF (Annual)1.14x

Revenue / Share (TTM)$0.00

ROE (TTM)-26.10%

52-Week Low$2.09

mGradeD

vgmGradeD

XBIT Earnings Surprise History

Q2 19-0.16est. -0.15

Q3 19-0.15est. -0.15

Q4 19-0.28est. -0.15

Q1 200.00est. 0.06

XBIT Analyst Recommendations

Sep 2021

Oct 2021

Nov 2021

Dec 2021

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
XBITXBiotech Inc	—	—	D	$2.30
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About XBiotech Inc

XBiotech is a clinical-stage biopharmaceutical company developing monoclonal antibodies using its proprietary True Human technology platform. The company focuses on anti-inflammatory therapeutic antibodies, primarily for oncology applications. All operations are based in the United States.